About: Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Sector: Healthcare
Industry: Medical Care Facilities
Latest price: $6.71 (-2.89%)
STLN NASDAQ The Oncology Institute, Inc.
The Oncology Institute, Inc. share price
STLN price activity
Last Price
$6.710
Change (24hr)
-0.20 USD (2.89%)
Volume
1.06M
Volume (4w avg)
-
Open
$6.92
Day Range
$6.66 - $6.95
Previous Close
$6.91
Last Trade
23 Oct, 8:00 pm GMT+0
Delayed
23 Oct, 8:00 pm GMT+0
STLN price performance
Delayed
23 Oct, 8:00 pm GMT+0
STLN Market Signals